The FDA told two compounding pharmacies in Montana and New York that it found serious deficiencies in their practices for producing sterile drugs, according to warning letters posted Jan. 19 on the FDA’s website.
The Food and Drug Administration said that based on inspections, the pharmacies appear to be producing drugs that violate the Federal Food, Drug, and Cosmetic Act (FDCA).
The pharmacies include Montana Compounding Pharmacy P.C. in Missoula, Mont., and MasterPharm LLC in South Richmond Hill, N.Y.
Montana Pharmacy.
The FDA told Montana Compounding Pharmacy in a letter dated Dec. 11, 2015, that the pharmacy isn’t receiving valid ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.